Concepedia
Publication | Open Access
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
601
Citations
28
References
2017
Year
Page 1